Health
Bionano Announces Preliminary 3Q 2024 Revenues and Cash
SAN DIEGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced select preliminary results for the quarter ended September 30, 2024. The Company now expects revenue for the third quarter of 2024 to be between $6.5 a
By: globenewswire_fr
- Oct 11 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS